Showing 346 to 360 of 491 results
Update on the Indicative Sanctions Policy review
In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.
What you need to do for annual monitoring 2019–20
This year we're asking you to provide extra evidence to show how your programme has monitored practice-based learning and the involvement of service users and carers
New independent adviser for innovation joins HCPC
The Health and Care Professions Council (HCPC) is pleased to announce that Dr Iain McGregor, Director of Innovation and Resources at the Government Internal Audit Agency (GIAA), has joined HCPC as Adviser to Council on Technology-Led Innovation.
HCPC launches consultation on permanent changes to our Rules to hold remote hearings
We launched a consultation on permanently amending our Rules to give us the express power to hold hearings remotely.
Early Direct Debit collections
It appears that due to a system error the usual direct debit collection for radiographers, orthoptists and paramedics has been claimed a week early. We apologise for any inconvenience that this may have caused.
Paramedic programmes non-ambulance practice-based learning: Understanding our requirements
We have produced an information sheet for education providers to enable consideration of our regulatory requirements and standards when developing in this area.
The HCPC is looking for four new Council members
Council members play a key part in setting strategy and policy for the HCPC and ensuring that public protection is at the heart of everything that we do.
How we use data in education decisions
This guidance is intended to help you understand how we use data in our education quality assurance work and to set some context to help you engage with our requirements and requests
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).